Story perspectives

New Insights on Early Detection of Rheumatoid Arthritis

9/30/2025

36 6

Summary

Story summary

Researchers identify a silent preclinical stage before rheumatoid arthritis, creating an opportunity for earlier intervention.
Anticitrullinated protein antibodies (ACPAs) indicate risk years before joint inflammation.
In a study of 45 ACPA-positive individuals, those who developed RA showed increased immune activity.
Abatacept may delay onset; the findings aim to improve RA prediction and treatment strategies, published in Science Translational Medicine.

1 of 1

Story summary

Researchers identify a silent preclinical stage before rheumatoid arthritis, creating an opportunity for earlier intervention.
Anticitrullinated protein antibodies (ACPAs) indicate risk years before joint inflammation.
In a study of 45 ACPA-positive individuals, those who developed RA showed increased immune activity.
Abatacept may delay onset; the findings aim to improve RA prediction and treatment strategies, published in Science Translational Medicine.